A new device designed to monitor fluctuations in intraocular pressure has completed its first trial in the US.
The Triggerfish device could be used to manage glaucoma, according to its Swiss-based manufacturer Sensimed.
An open label clinical study has been completed to investigate the safety and tolerability of using the device in 40 glaucoma suspects or patients, with a second study due to assess the efficacy of the product during wake and sleep.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
